Pathogenesis and therapy of acne: Current aspects;Pathogenese und therapie der akne: Aktuelle aspekte

Aktuelle Dermatologie

Volumn 33, Issue 4, 2007, Pages 137-141

  Ochsendorf, Falk R ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; ISOTRETINOIN; RETINOID;

ACNE; ACNE VULGARIS; BACTERIAL COLONIZATION; COMBINATION CHEMOTHERAPY; HUMAN; MAINTENANCE THERAPY; MONOTHERAPY; REVIEW; SEBORRHEA; SKIN INFLAMMATION;

EID: 34248358122     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-966124     Document Type: Review

References (34)

1. Rzany B, Kahl C. Epidemiologic der Acne vulgaris. J Dtsch Dermatol Ges 2006:4:8-9
2. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20-27
3. Moss C. Genetic control of sebum excretion and acne - a twin study. Br J Dermatol 1989; 121: 144-145
4. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136: 66-70
5. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297-300
6. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 2003; 206: 24-28
7. Blanche H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E, Dausset J, Bellanne-Chantelot C. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Human Genetics 1997; 101: 56-60
8. Degitz K Placzek M, Arnold B, Schmidt H, Plewig G. Congenital adrenal hyperplasia and acne in male patients. Br J Dermatol 2005; 148: 1263-1266
9. Placzek M, Arnold B, Schmidt H, Gaube S, Keller E, Plewig G, Degitz K. Elevated 17-hydroxyprogesterone serum values in male patients with acne. J Am Acad Dermatol 2005; 53: 955-958
10. Harde V, Muller M, Sippell WG, Schwarz T, Folster-Holst R. "Acne infantum" bei adrenogenitalem Syndrom als Folge eines 11-beta Hydroxylasemangels. J Dtsch Dermatol Ges 2006; 4: 654-657
11. Zouboulis CC. Moderne Aspekte der Aknepathogenese. Akt Dermatologie 2006; 32: 296-302
12. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 1992; 98: 895-901
13. Guy R, Green M, Kealey T. Modelling of acne in vitro. J Invest Dermatol 1996; 106: 176-182
14. Pawin H, Beylot C, Chivot M, Faure M, Poli F, Revuz J, Dreno B. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol 2004; 14: 4-12
15. Zouboulis CC, Eady AE, Philpott M, Goldsmith LA, Orfanos C, Cunlliffe W, Rosenfield R. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-152
16. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-676
17. Cunliffe W. Akne. Stuttgart: Hippokrates, 1993
18. Ozolins M, Eady AE, Avery AJ, Cunliffe WJ, Li Wan Po A, O'Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: a randomised controlled trial. Lancet 2004; 364: 2188-2195
19. Thielitz A, Gollnick H. Systemische Aknetherapie. J Dtsch Dermatol Ges 2005; 3: 366-378
20. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006; 142: 605-612
21. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, Kang S. Adapalene gel, 0.1 %, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597-602
22. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-595
23. Worret WI, Fluhr J. Topische Therapie mit Benzoyiperoxid, Antibiotika und Azelainsäure bei der Akne. J Dtsch Dermatol Ges 2006; 4: 293-300
24. Ochsendorf F. Systemische Antibiotika zur Therapie der Akne. J Dtsch Dermatol Ges 2006; 4: 828-841
25. Ochsendorf F. Clinical relevance of antibiotic resistance in acne. G Ital Dermatol Venereol 2006; 141: 183-186
26. Zouboulis CC. Therapie der Akne mit Antiandrogenen - eine Evidenzbasierte Übersicht. J Dtsch Dermatol Ges 2003; 1: 535-546
27. Layton AM, Dreno B, Gollnick HP, Zouboulis CC. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol. 2006; 20: 773-776
28. Degitz K, Plewig G. Ergänzende Verfahren in der Aknetherapie. J Dtsch Dermatol Ges 2005; 3: 92-96
29. Borelli C, Merk K, Plewig G, Degitz K. Licht, Laser und PDT-Therapie fur Akne. Hautarzt 2005; 56: 1027-1032
30. Friedman GD. Twin studies of disease heritability based on medical records: application to acne vulgaris. Acta Genet Med Gemeliol 1984; 33: 487-495
31. Walton S, Wyatt EH, Cunliffe WJ. Genetic control of sebum excretion and acne - a twin study. Br J Dermatol 1988; 118: 393-396
32. Cunliffe WJ. Natural history of acne. In: Marks R (ed). Acne and related disorders. London: M. Dunitz, 1989: 4-6
33. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119: 1317-1322
34. Evans DM, Kirk KM, Nyholt DR, Novae C, Martin NG. Teenage acne is influenced by genetic factors. Br J Dermatol 2005; 152: 579-581